The Chemours Company (CC) Fair Value 2026

CC · Specialty Chemicals ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.1 /10

32 fundamental signals · 5 models active

Value Trap Risk

SAFE (17/100)

Quick Summary — As of 2026-08-27, The Chemours Company (CC) trades at $15.88, versus a $30.29 median fair value across its 5 active models — 90.8% above the current price. QOC: 6.1/10. Value Trap Risk: 17/100 (SAFE). 5/13 models active.

Key Facts

Ticker
CC
Price
$15.88
Quality Score
6.1/10
Value Trap Risk
17/100
Models Active
5/13
Last Updated
Strength: CUCE Ensemble suggests +90.8% upside with 8% confidence
Risk: Limited model coverage (5/13) may reduce confidence

Is The Chemours Company (CC) Undervalued or Overvalued in 2026?

According to CirclFi’s 5-model valuation engine, The Chemours Company (CC) appears undervalued as of : the median of 5 independent fair value estimates is $30.29, 90.8% above the current price of $15.88. Estimates range from $2.83 to $71.41. CC scores 6.1/10 on fundamental quality and 17/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. CC’s +90.8% gap is wider than that market norm, and the Specialty Chemicals sector median is -35.9%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy The Chemours Company Stock in 2026? →

What Fair Value Does Each Model Give CC?

5 Intrinsic Value Models vs. Current Price ($15.88)

Core Models (Unlocked)
Model Fair Value Upside
Ensemble · Low Conviction
 $30.29 +90.8%
Intrinsic · High Conviction
 $2.83 -82.2%
Unlock the Full Matrix

Access 3 additional models including PWERM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 5 Models →

Cancel anytime · No contracts · Instant access

What Is CC's Fair Value Range?

Spread across 5 independent models · $2.83 to $71.41

CirclFi's 5 active models place The Chemours Company (CC) between $2.83 and $71.41 per share, a spread of 226% of the median. The median of that range — $30.29 — is the fair value CirclFi publishes for CC, against a current price of $15.88.

Low · RCMH-DCFHigh · Regime Cross
$2.83median $30.29$71.41
Where the range comes from
Most bearish modelRCMH-DCF$2.83
Most bullish modelRegime Cross-Sectional$71.41
Model agreement4 bullish · 1 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for CC. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on CC, not a CirclFi price target. How each model works →

What Is The Chemours Company (CC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, The Chemours Company is potentially undervalued at its current price of $15.88. Based on our 13-model framework, The Chemours Company's intrinsic value is estimated at a median fair value of $30.29 — representing +90.8% implied upside — with 4 out of 5 active models confirming this thesis. Model dispersion is worth noting: Regime Cross targets $71.41 (+349.7%), versus RCMH-DCF at $2.83 (-82.2%). This +431.9% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About CC?

5 of 13 models are currently active for CC. Of these, 4 models suggest upside while 1 model suggests overvaluation. Taken together, their median fair value for CC is $30.29 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does CC Rank in Specialty Chemicals?

Among 69 Specialty Chemicals stocks, CC ranks #47 by Quality of Company score. CirclFi's QOC score of 6.1/10 evaluates 32 fundamental signals. A score of 6.1 indicates above-average quality.

See all Most Undervalued Specialty Chemicals Stocks →

The Chemours Company's positioning within the Specialty Chemicals segment means that order backlog depth plays an outsized role in fundamental analysis. The sector's unique characteristics — including reshoring and supply chain localization — shape both the opportunity set and risk profile.

Is CC a Value Trap?

CirclFi's Value Trap algorithm assigns CC a score of 17/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

5 of 13 models are active for The Chemours Company. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, The Chemours Company earns a quality score of 6.1/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +431.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CC's 5 active models, average confidence is 33%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy The Chemours Company Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Specialty Chemicals Stocks Should You Also Analyze?

11 related Specialty Chemicals stocks with 13-model coverage

NNUPNocopi Technologies, Inc.QOC 6.3LWLGLightwave Logic, Inc.QOC 6.1ECVTEcovyst Inc.QOC 6.3FFFutureFuel Corp.QOC 6.1KROKronos Worldwide, Inc.QOC 6.4PRMPerimeter Solutions, Inc.QOC 6.0QGAIQuantum Genesis AI Corp.QOC 3.9CBTCabot CorporationQOC 8.6ALBAlbemarle CorporationQOC 7.2ODCOil-Dri Corporation of AmericaQOC 9.2RPMRPM International Inc.QOC 9.0

Read investment analysis: NNUP · LWLG · ECVT · FF · KRO · PRM · QGAI · CBT · ALB · ODC · RPM

Which Other Stocks Have a Similar Quality Score to CC?

7 companies across all industries closest to CC’s Quality of Company score of 6.1/10.

BBAIBigBear.ai Holdings, Inc.QOC 6.1TXOTXO Partners, L.P.QOC 6.1ECHOEchoStar CorporationQOC 6.1LOCLLocal Bounti CorporationQOC 6.1INCRInterCure Ltd.QOC 6.1AIRSAirSculpt Technologies, Inc.QOC 6.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: BBAI · TXO · ECHO · LOCL · INCR · AIRS · NVDA

Where Does CC Sit in CirclFi's Specialty Chemicals Rankings?

CC is ranked against every other Specialty Chemicals stock CirclFi covers in each of these screens.

See all Specialty Chemicals stocks ranked →

What Else Do Investors Ask About The Chemours Company’s Valuation?

What is The Chemours Company's intrinsic value in 2026?

CirclFi puts The Chemours Company (CC)'s intrinsic value at $30.29 — the median of 5 independent model estimates as of 2026-08-27, ranging from $2.83 to $71.41. The Quality of Company score is 6.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CC overvalued or undervalued right now?

At $15.88, 4 of 5 active models suggest CC may be undervalued, while 1 indicate potential overvaluation. The median of all 5 fair value estimates is $30.29, 90.8% above the current price of $15.88 — a consensus view that CC is undervalued. The assessment depends on which methodology best fits The Chemours Company's business model in Specialty Chemicals.

What does a Quality of Company score of 6.1 mean for CC?

The Chemours Company's QOC of 6.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on CC?

CirclFi analyzes CC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 5 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on CC?

Of the 5 models currently active on CC, Regime Cross-Sectional is the most bullish at $71.41 per share, and RCMH-DCF is the most bearish at $2.83. CirclFi's published fair value for CC is the median of that range, $30.29, not either extreme. The gap between the two ends equals 226% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is CC a value trap in 2026?

The Chemours Company's Value Trap score is 17/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 5-model valuation engine, The Chemours Company (CC) has a median fair value of $30.29 — 90.8% above the current price of $15.88 — as of 2026-08-27.” Source: circlfi.com/stock/CC/ · Methodology
Primary sources for this CC valuation
  • Financial statements: The Chemours Company 10-K and 10-Q filings on SEC EDGAR (CIK 0001627223) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CC as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 5 mathematical frameworks give you clarity on CC.

Unlock All 5 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

3 models hidden for CC Unlock All 5 — $39/mo